Growth momentum Solco Healthcare US LLC is a fast-growing generic pharma player ranking in the Top 10 U.S. market with a broad product pipeline and ongoing approvals, presenting opportunities to expand contracting and co-development discussions with payors, distributors, and healthcare systems.

Product portfolio With 56 FDA-approved products and nearly 40 pending approvals across cardiovascular, CNS, anti-infectives, antifungals, diuretics, muscle relaxants, and specialty segments, there is potential to target formularies and alignment for new generic launches and line extensions with wholesalers and retail chains.

Quality and compliance Manufacturing in GMP-certified facilities in Charlotte and China under strict FDA standards positions Solco as a reliable supplier for risk-averse customers; leverage this for competitive bidding, inventory planning, and supply chain stability discussions with hospitals, IDNs, and long-term care distributors.

Supply excellence Award-winning supply reliability can be highlighted in customer acquisition strategies to win national accounts, contract manufacturing opportunities, and steady-state replenishment programs with wholesalers and pharmacy chains seeking dependable generics partners.

Strategic backing As a wholly owned subsidiary of Prinston Pharmaceutical, Solco can explore co-marketing, strategic partnerships, and access to broader product development capabilities, enabling joint tenders and expanded geographic or channel penetration.